| Literature DB >> 29353538 |
Ivan Weinsanto1,2, Jinane Mouheiche1,2, Alexis Laux-Biehlmann1,2, Maya Aouad1,2, Tando Maduna1,2, Nathalie Petit-Demoulière1,2, Virginie Chavant1,2,3, Pierrick Poisbeau1,2, Pascal Darbon1,2, Alexandre Charlet1,2, Anne Giersch4, Marie-Odile Parat5, Yannick Goumon1,2,3.
Abstract
Background Lithium is widely used to treat bipolar disorders and displays mood stabilizing properties. In addition, lithium relieves painful cluster headaches and has a strong analgesic effect in neuropathic pain rat models. Objectives To investigate the analgesic effect of lithium on the cuff model of neuropathic pain. Methods We used behavioral and pharmacological approaches to study the analgesic effect of a single injection of lithium in wild-type and mu opioid receptor (MOR) null cuffed neuropathic mice. Mass spectrometry and enzyme-linked immunosorbent assay allowed to measure the levels of endogenous MOR agonist beta-endorphin as well as monoamines in brain and plasma samples 4 h after lithium administration. Results A single injection of lithium chloride (100 mg/kg, ip) alleviated mechanical allodynia for 24 h, and this effect was absent in MOR null neuropathic mice. Biochemical analyses highlight a significant increase in beta-endorphin levels by 30% in the brain of lithium-treated mice compared to controls. No variation of beta-endorphin was detected in the blood. Conclusions Together, our results provide evidence that lithium induces a long-lasting analgesia in neuropathic mice presumably through elevated brain levels of beta-endorphin and the activation of MORs.Entities:
Keywords: Lithium; analgesia; beta-endorphin; monoamines; mu opioid receptor; neuropathy
Mesh:
Substances:
Year: 2018 PMID: 29353538 PMCID: PMC5788089 DOI: 10.1177/1744806917754142
Source DB: PubMed Journal: Mol Pain ISSN: 1744-8069 Impact factor: 3.395